UB Paderborn / Katalog / Suche / in CDI

A Controlled Trial of Renal Denervation for Resistant Hypertension

The New England journal of medicine, 2014-04, Vol.370 (15), p.1393-1401

2014

Link zum Volltext

Verfügbarkeit prüfen

SYMPLICITY HTN-Japan　– First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients

Circulation Journal, 2015/05/25, Vol.79(6), pp.1222-1229

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

The New England journal of medicine, 2010-07, Vol.363 (2), p.136-146

2010

Link zum Volltext

Verfügbarkeit prüfen

Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial

Clinical cardiology (Mahwah, N.J.), 2012-09, Vol.35 (9), p.528-535

2012

Link zum Volltext

Verfügbarkeit prüfen

Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions

Kidney international, 2005-02, Vol.67 (2), p.706-713

2005

Link zum Volltext

Verfügbarkeit prüfen

12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension

Journal of the American College of Cardiology, 2015-04, Vol.65 (13), p.1314-1321

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure

Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.1071-1078

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction

The American heart journal, 2006, Vol.151 (1), p.168-175

2006

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial)

The American heart journal, 2011-05, Vol.161 (5), p.807-814

2011

Link zum Volltext

Verfügbarkeit prüfen

First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension

Hypertension (Dallas, Tex. 1979), 2015-04, Vol.65 (4), p.766-774

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

The Lancet (British edition), 2022-10, Vol.400 (10361), p.1405-1416

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3

Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.1071-1078

2014

Link zum Volltext

Verfügbarkeit prüfen

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

JAMA : the journal of the American Medical Association, 2013-12, Vol.310 (23), p.2510

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents: Final 5-Year Report of the RESOLUTE All-Comers Trial

Circulation. Cardiovascular interventions, 2015-06, Vol.8 (6), p.e002230-e002230

2015

Link zum Volltext

Verfügbarkeit prüfen

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial

Journal of the American College of Cardiology, 2015-04, Vol.65 (13), p.1314-1321

2015

Link zum Volltext

Verfügbarkeit prüfen

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial

Hypertension (Dallas, Tex. 1979), 2022-07, Vol.79 (7), p.101161HYPERTENSIONAHA12118641-1514

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Angiographic Results With the Next-Generation Resolute Stent System

JACC. Cardiovascular interventions, 2009-10, Vol.2 (10), p.977-985

2009

Link zum Volltext

Verfügbarkeit prüfen

The rise, fall, and possible resurrection of renal denervation

Nature reviews cardiology, 2016-04, Vol.13 (4), p.238

2016

Link zum Volltext

Verfügbarkeit prüfen

Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis

Journal of the American College of Cardiology, 2004-09, Vol.44 (6), p.1200-1209

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions

The American journal of cardiology, 2004-06, Vol.93 (12), p.1536-1539

2004

Link zum Volltext

Verfügbarkeit prüfen

Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry

Journal of hypertension, 2016-12, Vol.34 (12), p.2480-2486

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial

JACC. Cardiovascular interventions, 2009-10, Vol.2 (10), p.977-985

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of Anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty complications (CADILLAC) trial

Journal of the American College of Cardiology, 2004-08, Vol.44 (3), p.547-553

2004

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

Heart (British Cardiac Society), 2013-09, Vol.99 (17), p.1267-1274

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program

Heart (British Cardiac Society), 2013-05, Vol.99 (9), p.626-633

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Controlled Trial of Renal Denervation for Resistant Hypertension

SYMPLICITY HTN-Japan　– First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial

Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions

12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension

Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure

Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction

Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial)

First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents: Final 5-Year Report of the RESOLUTE All-Comers Trial

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial

Clinical and Angiographic Results With the Next-Generation Resolute Stent System

The rise, fall, and possible resurrection of renal denervation

Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis

Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions

Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry

Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial

Impact of Anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty complications (CADILLAC) trial

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program

Suchergebnisse filtern